REFERENCES
- Gerrard R. The National Blood Service. Supporting better blood transfusion. Br J Perioper Nurs. 2004;14(5):215–220.
- Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007; 17(4):850–858.
- Johnson CS. Arterial blood pressure and hyperviscosity in sickle cell disease. Hematol Oncol Clin North Am. 2005;19(5):827–837.
- The Management of Sickle Cell Disease. NIH, NHLBI Publication No. 02-2117, 2002; 4th edition.
- Smith-Whitley K, Zhao H, Hodinka RL, Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004;103(2):422–427.
- Josephson CD, Su LL, Hillyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev. 2007;21(2):118–133.
- Win N, New H, Lee E, de la Fuente J. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion. 2008;48(6):1231–1238.
- Danielson CF. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher. 2002;6(1):24–31.
- Adams RJ, McKie VC, Hsu L, Prevention of a first stroke by transfusion in children with abnormal results of transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5–11.
- Adams RJ, Brambilla D. Optimizing primary stroke prevention in sickle cell anemia (STOP 2) trial investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353(26):2769–2778.
- National Heart, Lung, and Blood Institute (NHLBI), Stroke With Transfusions Changing to Hydroxyurea (SWiTCH), NCT00122980 June 25, 2010.
- Charache S, Terrin ML, Moore RD, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332(20):1317–1322.
- Vichinsky EP, Haberkern CM, Neumayr L, A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995;333(4):206–213.
- Al-Jaouni S, Al-Muhayawi S, Qari M, Nawas MA, Abdel-Razeq H. The safety of avoiding transfusion preoperatively in patients with sickle cell hemoglobinopathies (Abstract). Blood. 2002;100(11, Pt. 2):21b.
- Hirst C, Williamson L. Preoperative blood transfusions for sickle cell disease. Cochrane Database of Systematic Reviews. 2001; Issue 3. Art. No.: CD003149. DOI: 10.1002/14651858.CD003149.
- Styles LA, Abboud M, Larkin S, Lo M, Kuypers FA. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol. 2007;136(2):343–344.